<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND/AIMS: Hedgehog (Hh) pathway has been considered as a therapy target for various <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> entities </plain></SENT>
<SENT sid="1" pm="."><plain>However, its mechanism in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> is still unclear </plain></SENT>
<SENT sid="2" pm="."><plain>METHODOLOGY: We analyzed the expression of Hh pathway members in colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell lines and then studied its relationship with survival of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells through inhibiting Hh pathway by cyclopamine </plain></SENT>
<SENT sid="3" pm="."><plain>Moreover, we studied the regulation of Gli1 on insulin-like growth factor binding protein 6 (IGFBP6) and <z:e sem="disease" ids="C0023434" disease_type="Neoplastic Process" abbrv="BCLL">B-cell CLL</z:e>/<z:hpo ids='HP_0002665'>lymphoma</z:hpo> 2 (Bcl-2) genes at the level of transcription by XChIP and cyclopamine inhibition assay </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Sonic hedgehog (Shh), Smoothened (Smo), patched (Ptch) and Gli1 genes <z:chebi fb="2" ids="33699">mRNA</z:chebi> were expressed in SW116 cells </plain></SENT>
<SENT sid="5" pm="."><plain>Gli1 bound to promoter regions of Bcl-2 and IGFBP6 genes, cyclopamine inhibited proliferation and induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> through inhibiting the transcriptions of IGFBP6 (p=0.003), proliferating cell nuclear antigen (PCNA) (p=0.014) and Bcl-2 (p=0.013), and increasing that of BCL2-associated X protein (Bax) and BCL2-<z:chebi fb="68" ids="48706">antagonist</z:chebi>/killer 1 (Bak1) (p=0.003 and 0.001, respectively) in SW116 cells </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Hh pathway is aberrant activation in part colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> cell lines and its inhibitor may be an effectual agent for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> chemoprevention </plain></SENT>
<SENT sid="7" pm="."><plain>It may be one of the mechanisms that Gli1 maintained cell survival by binding the promoter regions and facilitating transcription of IGFBP6 and Bcl-2 genes </plain></SENT>
</text></document>